Skip to main content
. 2021 Aug 18;59(9):e01123-21. doi: 10.1128/JCM.01123-21

TABLE 2.

Pooled testing results as of 9 April 2021a

Metric Value %
No. of pooled tests run 39,297 100
No. of negative poolsb 38,593 98.2
No. of positive poolsc 310 0.8
No. of invalid poolsd 31 0.1
No. of inconclusive poolse 67 0.2
Unsatisfactory specimens (test not performed)
    Reason: at least one swab upside down in tube 215 0.6
    Reason: lab incident 46 0.1
    Reason: sample received >56 h after collectionf 26 0.1
    Reason: sample too viscous after rehydration 3 0.01
    Reason: tube label data do not match order 2 0.01
Positive pool viral N1 target CT, mean (SD) 26.4 (5.6)
Positive pool viral N1 target CT, range 15.3–37.8
Positive pool viral N2 target CT, mean (SD) 27.9 (6.3)
Positive pool viral N2 target CT, range 15.7–39.8
a

Results are based on a RT-PCR with multiplexed N1, N2, and RP targets as outlined in the assay EUA (EUA200147). CT, cycle threshold.

b

Negative pools have no detected viral targets and a positive human control target (RP gene).

c

Positive pools have two detected viral targets (N1 and N2).

d

Invalid pools have no detected viral targets and no detected human control target.

e

Inconclusive pools have only one viral target detected.

f

Acceptable specimens for testing must be received at the laboratory within 56 h of collection based on FDA stability studies.